|
⚲
|
| Keyboard |
| Sinaf SA
✚
|
|
|---|---|
| CIK # | 0001495790 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001495790] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Sinaf SA | |
| Regenerx Biopharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Regenerx Biopharmaceuticals Inc RGRX
Convertible Promissory Note (right to buy) · derivative
|
2018-03-13 | Sell | $150,000.00 | ||
|
Regenerx Biopharmaceuticals Inc RGRX
Common Stock
|
2018-03-13 | Sell | 11,584,795 | $0.23 | 2,664,503 |
|
Regenerx Biopharmaceuticals Inc RGRX
Common Stock
|
2017-10-13 | Other | 266,667 | ||
|
Regenerx Biopharmaceuticals Inc RGRX
Common Stock Warrant (right to buy) · derivative
|
2017-10-13 | Other | 266,667 | ||
|
Regenerx Biopharmaceuticals Inc RGRX
Common Stock
|
2017-10-13 | Conversion | 1,671,296 | ||
|
Regenerx Biopharmaceuticals Inc RGRX
Convertible Promissory Note (right to buy) · derivative
|
2017-10-13 | Conversion | 1,671,296 | ||
|
Regenerx Biopharmaceuticals Inc RGRX
Common Stock
|
2014-02-03 | Other | 64,575 | $0.00 | |
|
Regenerx Biopharmaceuticals Inc RGRX
Convertible Promissory Note (right to buy) · derivative
|
2013-09-12 | Buy | $150,000.00 | ||
|
Regenerx Biopharmaceuticals Inc RGRX
Convertible Promissory Note (right to buy) · derivative
|
2012-10-19 | Buy | 1 | $200,000.00 | 200,000 |
|
Regenerx Biopharmaceuticals Inc RGRX
Common Stock Warrant (right to buy) · derivative
|
2012-10-19 | Other |